De Matteis Giuseppe, Burzo Maria Livia, Serra Amato, Della Polla Davide Antonio, Nicolazzi Maria Anna, Simeoni Benedetta, Gasbarrini Antonio, Franceschi Francesco, Gambassi Giovanni, Covino Marcello
Department of Internal Medicine, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
Division of Internal Medicine, Ospedale Santo Spirito in Sassia, Rome, Italy.
Intern Emerg Med. 2025 Jan;20(1):95-104. doi: 10.1007/s11739-024-03754-w. Epub 2024 Sep 3.
Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are often coexisting conditions, but their interrelationship has not yet been clarified. This study investigated the clinical characteristics and prognostic impact of AF among older patients with HFpEF hospitalized for acute HF (AHF). The study included patients 65 years of age and older who were admitted to the Emergency Department due to AHF from 1 January 2016 to 31 December 2019. Patients were divided into two groups according to the presence of AF. The primary endpoint was all-cause, in-hospital mortality. Overall, 770 patients with HFpEF were included, mean age 82 years, 53% were females. Nearly, a third (30%) of these patients had a concomitant AF and they were significantly older and had higher N-Terminal pro-B-type natriuretic peptide (NT-proBNP) values. Overall, the in-hospital mortality rate was much higher among HFpEF patients with AF compared to those without AF (11.4% vs 6.9%, respectively; p = 0.037). At multivariate analysis, AF emerged as an independent risk factor for death (OR 1.73 [1.03-2.92]; p = 0.038). Among older patients with HFpEF admitted for AHF, the coexistence of AF was associated with a nearly twofold increased risk of all-cause in-hospital mortality. Patients with HFpEF and AF describe a phenotype of older and more symptomatic patients, with higher NT-proBNP, left atrial enlargement, right ventricular dysfunction, and higher CV mortality.
射血分数保留的心力衰竭(HFpEF)与心房颤动(AF)常并存,但它们之间的相互关系尚未阐明。本研究调查了因急性心力衰竭(AHF)住院的老年HFpEF患者中AF的临床特征及其对预后的影响。该研究纳入了2016年1月1日至2019年12月31日因AHF入住急诊科的65岁及以上患者。根据是否存在AF将患者分为两组。主要终点是全因院内死亡率。总体而言,共纳入770例HFpEF患者,平均年龄82岁,53%为女性。其中近三分之一(30%)的患者合并AF,他们年龄更大,N末端B型利钠肽原(NT-proBNP)值更高。总体而言,合并AF的HFpEF患者的院内死亡率远高于未合并AF的患者(分别为11.4%和6.9%;p = 0.037)。多因素分析显示,AF是死亡的独立危险因素(OR 1.73 [1.03 - 2.92];p = 0.038)。在因AHF住院的老年HFpEF患者中,AF的并存与全因院内死亡率增加近两倍相关。合并HFpEF和AF的患者表现为年龄更大、症状更明显的患者表型,NT-proBNP更高、左心房扩大、右心室功能障碍以及心血管死亡率更高。